Skip to main navigation Skip to search Skip to main content

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

  • Andrew M. Evens
  • , Steven T. Rosen
  • , Irene Helenowski
  • , Justin Kline
  • , Annette Larsen
  • , Jennifer Colvin
  • , Jane N. Winter
  • , Koen M. van Besien
  • , Leo I. Gordon
  • , Sonali M. Smith

Research output: Contribution to journal › Article › peer-review

48   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science